| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |